← SynDRA
OMACETAXINE MEPESUCCINATE
SynDRA canonical compound SYN0002329 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | RPL3 |
|---|
| Mechanism of action | protein synthesis inhibitor |
|---|
| Indication | chronic myeloid leukemia (CML) |
|---|
| Disease area | hematologic malignancy |
|---|
All known targets
Mechanisms of action (all sources)
- protein synthesis inhibitor
Drug classes
- Antineoplastic Agents
- Antineoplastic Agents, Phytogenic
- Enzyme Inhibitors
- Protein Synthesis Inhibitors
ATC classes
- L01X · OTHER ANTINEOPLASTIC AGENTS
Cross-references
Synonyms
- synribo
- homoharringtonine
- CGX-635
- NSC-141633
- Mepesuccinate d'omacetaxine
- Mepesuccinato de omacetaxina
- Ceflatonin
- Homoharringtonin
- Myelostat
- Omapro
- HOMOHARRINGTONINE
- Synribo
- Synribo (TN)
- BRD-K76674262
- (-)-homoharringtonine
- NSC 141633
- C29H39NO9
- CHEBI:71019
- (2'R,3S,4S,5R)-(-)-homoharringtonine
- Omacetaxine (homoharringtonine)
- Omacetaxine mepesuccinate [USAN]
- 6FG8041S5B
- 1-O-[(2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-yl] 4-O-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate
- Cephalotaxine 4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate
- Omacetaxine mepesuccinate (USAN)
- Tekinex
- Cephalotaxine, 4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester)
- UNII-6FG8041S5B
- NSC141633
- NCGC00025155-01
- Omacetaxine mepesuccinate [USAN:INN]
- BRN 5687925
- omacetaxini mepesuccinas
- ZJ-C
- mepesuccinate d'omacetaxine
- mepesuccinato de omacetaxina
- Cephalotaxine 4-Methyl (2R)-2-Hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (Ester)
- MLS001424293
Look up OMACETAXINE MEPESUCCINATE in the interactive SynDRA portal →